Phase 1 Study of Oral TP-1454
NCT04328740
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
31
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Solid Tumor
Anal Cancer
Interventions
DRUG:
TP-1454 monotherapy
Sponsor
Sumitomo Pharma America, Inc.